Nephrocare Health Services Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
A withheld summary was generated but did not pass Parakho's publication checks; nothing that fails a check is shown. How we check these summaries
Nephrocare Health Services (NephroPlus) reported FY26 revenue growth of 32% to Rs 998.8 crore and adjusted EBITDA growth of 37% to Rs 238.2 crore, with adjusted PAT up 75%. Management attributed growth to same-clinic ramp-up, new clinic rollouts in India and overseas, and a rising mix of international revenue, while flagging a one-time Rs 10 crore expected credit loss provision that reduced Q4 margins. The company also discussed its expansion plans in the Philippines, Uzbekistan and Saudi Arabia, and reiterated a medium-term revenue growth framework.